45
Views
77
CrossRef citations to date
0
Altmetric
Cell Growth and Development

BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer

, , &
Pages 5900-5913 | Received 28 Oct 2003, Accepted 06 Apr 2004, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mahnaz Razandi, Ali Pedram & Ellis R. Levin. (2010) Heat Shock Protein 27 Is Required for Sex Steroid Receptor Trafficking to and Functioning at the Plasma Membrane. Molecular and Cellular Biology 30:13, pages 3249-3261.
Read now

Articles from other publishers (76)

Raja Rajeswari Rajeshkumar, Parasuraman Pavadai, Theivendren Panneerselvam, Venkataraman Deepak, Sureshbabu Ram Kumar Pandian, Shanmugampillai Jeyarajaguru Kabilan, Sivakumar Vellaichamy, Anbu Jeyaraman, A. Santhana Krishna Kumar, Krishnan Sundar & Selvaraj Kunjiappan. (2023) Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Nabilah Ibnat & Ezharul Hoque Chowdhury. (2023) Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes. Scientific Reports 13:1.
Crossref
Sina Taefehshokr, Nima Taefehshokr, Afshin Derakhshani, Amir Baghbanzadeh, Reza Vaezi Astamal, Sahar Safaei, Samane Abbasi, Saba Hajazimian, Nazila Fathi Maroufi, Alireza Isazadeh, Khalil Hajiasgharzadeh & Behzad Baradaran. (2022) The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer. Current Molecular Medicine 22:3, pages 263-273.
Crossref
Md Sohel, Partha Biswas, Md. Al Amin, Md. Arju Hossain, Habiba Sultana, Dipta Dey, Suraiya Aktar, Arifa Setu, Md. Sharif Khan, Priyanka Paul, Md. Nurul Islam, Md. Ataur Rahman, Bonglee Kim & Abdullah Al Mamun. (2022) Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms. Processes 10:2, pages 415.
Crossref
Marco Fiocchetti, Giovanna Bastari, Manuela Cipolletti, Stefano Leone, Filippo Acconcia & Maria Marino. (2021) The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells. Toxics 9:10, pages 237.
Crossref
Shiza Malik, Samra Khalid, Haidar Ali, Maham Khan, Faryal Mehwish, Aneela Javed, Fazal Akbar, Rumeza Hanif & Muhammad Suleman. (2020) In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancer. Gene Reports 21, pages 100938.
Crossref
Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio & Andrea Fabbri. (2019) RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Shyama Majumdar, Jaqueline C Rinaldi, Neha R Malhotra, Lishi Xie, Dan-Ping Hu, Timothy D Gauntner, Harinder S Grewal, Wen-Yang Hu, Sung Hoon Kim, John A Katzenellenbogen, Susan Kasper & Gail S Prins. (2019) Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells. Endocrinology 160:11, pages 2692-2708.
Crossref
Shuan Rao, Shane J.F. Cronin, Verena Sigl & Josef M. Penninger. (2018) RANKL and RANK: From Mammalian Physiology to Cancer Treatment. Trends in Cell Biology 28:3, pages 213-223.
Crossref
Massimo Pregnolato, Giuseppe Damiani & Alfredo Pereira Jr.. (2017) Patterns of calcium signaling: A link between chronic emotions and cancer. Journal of Integrative Neuroscience 16:s1, pages S43-S63.
Crossref
Boyoung Park, John L. Hopper, Aung K. Win, James G. Dowty, Ho Kyung Sung, Choonghyun Ahn, Sung-Won Kim, Min Hyuk Lee, Jihyoun Lee, Jong Won Lee, Eunyoung Kang, Jong-Han Yu, Ku Sang Kim, Byung-In Moon, Wonshik Han, Dong-Young Noh & Sue K. Park. (2017) Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers . Oncotarget 8:60, pages 102110-102118.
Crossref
Ju-Yeon KimHyeong-Gon MoonYoung-Joon KangWonshik HanWoo-Chul NohYongsik JungByung-In MoonEunyoung KangSung-Shin ParkMin Hyuk LeeBo Young ParkJong Won LeeDong-Young Noh. (2017) The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier . Journal of Breast Cancer 20:3, pages 279.
Crossref
Verena Sigl, Laundette P. Jones & Josef M. Penninger. (2016) RANKL/RANK: from bone loss to the prevention of breast cancer. Open Biology 6:11, pages 160230.
Crossref
F. Asghari, N. Haghnavaz, B. Baradaran, M. Hemmatzadeh & T. Kazemi. (2016) Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer. Biomedicine & Pharmacotherapy 81, pages 305-317.
Crossref
Zhengxi Wei, Xiulong Song & Zahir A. Shaikh. (2015) Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation. Toxicology and Applied Pharmacology 289:1, pages 98-108.
Crossref
Jun Liu, Zhixiang Xu, Xiaodong Ma, Bin Huang & Xuejun Pan. (2015) Role of ER-α36 in breast cancer by typical xenoestrogens. Tumor Biology 36:10, pages 7355-7364.
Crossref
Liang Shi, Tian-Song Xia, Xiao-Long Wei, Wenbin Zhou, Jinqiu Xue, Lin Cheng, Peipei Lou, Chunlian Li, Ying Wang, Ji-Fu Wei & Qiang Ding. (2015) Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer. Oncotarget 6:14, pages 12264-12278.
Crossref
Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Bruno Buecher, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Valérie Bonadona, Jean-Pierre Fricker, Pascaline Berthet, Olivier Caron, Isabelle Coupier, Pascal Pujol, Laurence Faivre, Paul Gesta, François Eisinger, Véronique Mari, Laurence Gladieff, Alain Lortholary, Elisabeth Luporsi, Dominique Leroux, Laurence Venat-Bouvet, Christine M. Maugard, Chrystelle Colas, Julie Tinat, Christine Lasset & Nadine Andrieu. (2015) Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers . Cancer Epidemiology, Biomarkers & Prevention 24:4, pages 698-707.
Crossref
Y Gu, P Bouwman, D Greco, J Saarela, B Yadav, J Jonkers & S G Kuznetsov. (2014) Suppression of BRCA1 sensitizes cells to proteasome inhibitors. Cell Death & Disease 5:12, pages e1580-e1580.
Crossref
Ellis R. Levin. (2014) Translating Extranuclear Steroid Receptor Signaling to Clinical Medicine. Hormones and Cancer 5:3, pages 140-145.
Crossref
C. Elizabeth Caldon. (2014) Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers. Frontiers in Oncology 4.
Crossref
Ryonosuke Yamaga, Kazuhiro Ikeda, Joost Boele, Kuniko Horie-Inoue, Ken-ichi Takayama, Tomohiko Urano, Kaoru Kaida, Piero Carninci, Jun Kawai, Yoshihide Hayashizaki, Yasuyoshi Ouchi, Michiel de Hoon & Satoshi Inoue. (2014) Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping. Biochemical and Biophysical Research Communications 447:3, pages 531-536.
Crossref
Matthew M. Roforth, Elizabeth J. Atkinson, Ellis R. Levin, Sundeep Khosla & David G. Monroe. (2014) Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing. PLoS ONE 9:4, pages e95987.
Crossref
Stephen R. Hammes, Susanne U. Miedlich & Aritro Sen. 2014. Steroid Receptors. Steroid Receptors 95 108 .
Marilena Kampa, Vassiliki Pelekanou, George Notas, Efstathios N. Stathopoulos & Elias Castanas. (2013) The estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?. Hormones 12:1, pages 69-85.
Crossref
Ashish Juvekar, Laura N. Burga, Hai Hu, Elaine P. Lunsford, Yasir H. Ibrahim, Judith Balmañà, Anbazhagan Rajendran, Antonella Papa, Katherine Spencer, Costas A. Lyssiotis, Caterina Nardella, Pier Paolo Pandolfi, José Baselga, Ralph Scully, John M. Asara, Lewis C. Cantley & Gerburg M. Wulf. (2012) Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer. Cancer Discovery 2:11, pages 1048-1063.
Crossref
Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Marion Gauthier-Villars, Christine Lasset, Jean-Pierre Fricker, Olivier Caron, Dominique Stoppa-Lyonnet, Pascaline Berthet, Laurence Faivre, Valérie Bonadona, Bruno Buecher, Isabelle Coupier, Laurence Gladieff, Paul Gesta, François Eisinger, Marc Frénay, Elisabeth Luporsi, Alain Lortholary, Chrystelle Colas, Catherine Dugast, Michel Longy, Pascal Pujol, Julie Tinat, Rosette Lidereau & Nadine Andrieu. (2012) Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Research 14:4.
Crossref
Allison W. Welsh, Donald R. Lannin, Gregory S. Young, Mark E. Sherman, Jonine D. Figueroa, N. Lynn Henry, Lisa Ryden, Chungyeul Kim, Richard R. Love, Rachel Schiff & David L. Rimm. (2012) Cytoplasmic Estrogen Receptor in Breast Cancer. Clinical Cancer Research 18:1, pages 118-126.
Crossref
Kazuhiro Takahashi, Shunai Piao, Hizuru Yamatani, Botao Du, Limei Yin, Tsuyoshi Ohta, Jun Kawagoe, Keiko Takata, Seiji Tsutsumi & Hirohisa Kurachi. (2011) Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells. Molecular and Cellular Neuroscience 48:3, pages 217-224.
Crossref
Ranmal Aloka Samarasinghe, Roberto Di Maio, Daniela Volonte, Ferruccio Galbiati, Marcia Lewis, Guillermo Romero & Donald B. DeFranco. (2011) Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proceedings of the National Academy of Sciences 108:40, pages 16657-16662.
Crossref
Priscilla A. Furth, M. Carla Cabrera, Edgar S. Díaz-Cruz, Sarah Millman & Rebecca E. Nakles. (2011) Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models. Annals of the New York Academy of Sciences 1229:1, pages 147-155.
Crossref
Kathleen A. Wilson, Sierra A. Colavito, Vincent Schulz, Patricia Heffernan Wakefield, William Sessa, David Tuck & David F. Stern. (2011) NFBD1/MDC1 Regulates Cav1 and Cav2 Independently of DNA Damage and p53. Molecular Cancer Research 9:6, pages 766-781.
Crossref
Laura N Burga, Hai Hu, Ashish Juvekar, Nadine M Tung, Susan L Troyan, Erin W Hofstatter & Gerburg M Wulf. (2011) Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Research 13:2.
Crossref
Lilia Antonova, Kristan Aronson & Christopher R Mueller. (2011) Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Research 13:2.
Crossref
. 2011. Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy. Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy 249 347 .
Rosa Sirianni, Adele Chimento, Arianna De Luca, Ivan Casaburi, Pietro Rizza, Arianna Onofrio, Domenico Iacopetta, Francesco Puoci, Sebastiano Andò, Marcello Maggiolini & Vincenzo Pezzi. (2010) Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Molecular Nutrition & Food Research 54:6, pages 833-840.
Crossref
Li Yu & Peng Shen. (2009) A variant of human estrogen receptor-α, hER-α36 weakens docetaxel drug efficacy against human breast cancer cell line MCF-7. Chinese Journal of Cancer Research 21:4, pages 325-332.
Crossref
L. Rensing & V. Rippe. (2009) Ist psychischer Stress ein Risikofaktor bei der Entstehung und Entwicklung von Tumoren?Is psychological stress a risk factor for the induction and development of tumors?. Der Onkologe 15:8, pages 784-791.
Crossref
Christopher K Taylor, Robert M Levy, Jay C Elliott & Bruce P Burnett. (2009) The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutrition Reviews 67:7, pages 398-415.
Crossref
Jun-Hua Peng, Feng Zhang, Hua-Xing Zhang & Hong-Yan Fan. (2009) Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERα expression and reduce rat mammary tumorigenesis. Cancer Epidemiology 33:1, pages 51-55.
Crossref
M. Graeser, K. Bosse, M. Brosig, C. Engel & R. K. Schmutzler. (2009) Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer. Virchows Archiv 454:5, pages 519-524.
Crossref
JL Malone, AC Nelson, R Lieberman, S Anderson & JT Holt. (2009) Oestrogen-mediated phosphorylation and stabilization of BRCA2 protein in breast. The Journal of Pathology 217:3, pages 380-388.
Crossref
J Wen, R Li, Y Lu & M A Shupnik. (2008) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions. Oncogene 28:4, pages 575-586.
Crossref
Eliot M. Rosen, Yongxian Ma & Saijun Fan. 2009. Hormone Receptors in Breast Cancer. Hormone Receptors in Breast Cancer 1 20 .
Ellis R. Levin. 2009. Hormone Receptors in Breast Cancer. Hormone Receptors in Breast Cancer 1 10 .
Herbert Marini, Alessandra Bitto, Domenica Altavilla, Bruce P. Burnett, Francesca Polito, Vincenzo Di Stefano, Letteria Minutoli, Marco Atteritano, Robert M. Levy, Rosario D'Anna, Nicola Frisina, Susanna Mazzaferro, Francesco Cancellieri, Maria Letizia Cannata, Francesco Corrado, Alessia Frisina, Vincenzo Adamo, Carla Lubrano, Carlo Sansotta, Rolando Marini, Elena Bianca Adamo & Francesco Squadrito. (2008) Breast Safety and Efficacy of Genistein Aglycone for Postmenopausal Bone Loss: A Follow-Up Study. The Journal of Clinical Endocrinology & Metabolism 93:12, pages 4787-4796.
Crossref
Maria Hietala, Håkan Olsson & Helena Jernström. (2007) Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Familial Cancer 7:3, pages 221-228.
Crossref
Jessie I. Luoma, Marissa I. Boulware & Paul G. Mermelstein. (2008) Caveolin proteins and estrogen signaling in the brain. Molecular and Cellular Endocrinology 290:1-2, pages 8-13.
Crossref
Grazia Arpino, Lisa Wiechmann, C. Kent Osborne & Rachel Schiff. (2008) Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance. Endocrine Reviews 29:2, pages 217-233.
Crossref
Ellis R. Levin & Richard J. Pietras. (2007) Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Research and Treatment 108:3, pages 351-361.
Crossref
Lilia Antonova & Christopher R. Mueller. (2008) Hydrocortisone down-regulates the tumor suppressor geneBRCA1 in mammary cells: A possible molecular link between stress and breast cancer. Genes, Chromosomes and Cancer 47:4, pages 341-352.
Crossref
Lev M Berstein. (2008) Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis . Future Oncology 4:1, pages 23-39.
Crossref
L P Jones, M T Tilli, S Assefnia, K Torre, E D Halama, A Parrish, E M Rosen & P A Furth. (2007) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer. Oncogene 27:6, pages 794-802.
Crossref
Kay HorschHeidi de WetMacé M. SchuurmansFatima Allie-ReidAndrew C. B. CatoJohn CunninghamJacky M. Burrin, F. Stephen HoughPhilippa A. Hulley. (2007) Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation. Molecular Endocrinology 21:12, pages 2929-2940.
Crossref
Stephen R. HammesEllis R. Levin. (2007) Extranuclear Steroid Receptors: Nature and Actions. Endocrine Reviews 28:7, pages 726-741.
Crossref
Jin-Qiang Chen, Patricia A. Russo, Carol Cooke, Irma H. Russo & Jose Russo. (2007) ERβ shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773:12, pages 1732-1746.
Crossref
James D. Yager & Jin Q. Chen. (2007) Mitochondrial estrogen receptors – new insights into specific functions. Trends in Endocrinology & Metabolism 18:3, pages 89-91.
Crossref
Nader Hussein, Huguette Casse, Sandra Fontanière, Anne-Marie Morera, Marie J. Asensio, Skander Bakeli, Jie L. Lu, Isabelle Coste, Nathalie Di Clemente, Philippe Bertolino & Chang X. Zhang. (2007) Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis. European Journal of Cancer 43:2, pages 402-414.
Crossref
Aleksandra Jovanovic PooleYing LiYoon KimSuh-Chin J. LinWen-Hwa LeeEva Y.-H. P. Lee. (2006) Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist . Science 314:5804, pages 1467-1470.
Crossref
P B Mullan, J E Quinn & D P Harkin. (2006) The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25:43, pages 5854-5863.
Crossref
Ali Pedram, Mahnaz Razandi & Ellis R. Levin. (2006) Nature of Functional Estrogen Receptors at the Plasma Membrane. Molecular Endocrinology 20:9, pages 1996-2009.
Crossref
Mohamed K. El-Tanani, Frederick Charles Campbell, Paul Crowe, Pauline Erwin, Denis Paul Harkin, Paul Pharoah, Bruce Ponder & Philip S. Rudland. (2006) BRCA1 Suppresses Osteopontin-mediated Breast Cancer. Journal of Biological Chemistry 281:36, pages 26587-26601.
Crossref
Paolo Ascenzi, Alessio Bocedi & Maria Marino. (2006) Structure–function relationship of estrogen receptor α and β: Impact on human health. Molecular Aspects of Medicine 27:4, pages 299-402.
Crossref
ZhaoYi WangXinTian ZhangPeng Shen, Brian W. LoggieYunChao Chang & Thomas F. Deuel. (2006) A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proceedings of the National Academy of Sciences 103:24, pages 9063-9068.
Crossref
Ali Pedram, Mahnaz Razandi, Douglas C. Wallace & Ellis R. Levin. (2006) Functional Estrogen Receptors in the Mitochondria of Breast Cancer Cells. Molecular Biology of the Cell 17:5, pages 2125-2137.
Crossref
Eliot M. Rosen, Saijun Fan & Yongxian Ma. (2006) BRCA1 regulation of transcription. Cancer Letters 236:2, pages 175-185.
Crossref
Nadine Andrieu, David E. Goldgar, Douglas F. Easton, Matti Rookus, Richard Brohet, Antonis C. Antoniou, Susan Peock, Gareth Evans, Diana Eccles, Fiona Douglas, Catherine Noguès, Marion Gauthier-Villars, Agnès Chompret, Flora E. Van Leeuwen, Irma Kluijt, Javier Benitez, Brita Arver, Edith Olah & Jenny Chang-Claude. (2006) Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI: Journal of the National Cancer Institute 98:8, pages 535-544.
Crossref
M Bramley, R B Clarke, A Howell, D G R Evans, T Armer, A D Baildam & E Anderson. (2006) Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations. British Journal of Cancer 94:7, pages 1021-1028.
Crossref
E. M. Rosen, S. Fan, Y. Ma & E. R. Levin. (2006) Role of plasma membrane ER protein in breast cancer. Breast Cancer Online 9:03.
Crossref
Margaret Warner & Jan-Åke Gustafsson. (2006) Nongenomic effects of estrogen: Why all the uncertainty?. Steroids 71:2, pages 91-95.
Crossref
Ellis R. Levin. (2005) Integration of the Extranuclear and Nuclear Actions of Estrogen. Molecular Endocrinology 19:8, pages 1951-1959.
Crossref
E. M. Rosen & S. Fan. (2005) Inhibition of estrogen receptor signaling. Breast Cancer Online 8:3.
Crossref
Ryota Ise, Dalho Han, Yusuke Takahashi, Shunichi Terasaka, Akio Inoue, Masao Tanji & Ryoiti Kiyama. (2005) Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Letters 579:7, pages 1732-1740.
Crossref
Vessela N. Kristensen, Therese Sørlie, Jurgen Geisler, Anita Langerød, Noriko Yoshimura, Rolf Kåresen, Nobuhiro Harada, P.E. Lønning & Anne-Lise Børresen-Dale. (2005) Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications. Clinical Cancer Research 11:2, pages 878s-883s.
Crossref
Therese Sørlie. (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. European Journal of Cancer 40:18, pages 2667-2675.
Crossref
Stavros C. Manolagas, Stavroula Kousteni, Jin-Ran Chen, Maria Schuller, Lilian Plotkin & Teresita Bellido. (2004) Kinase-mediated transcription, activators of nongenotropic estrogen–like signaling (ANGELS), and osteoporosis: A different perspective on the HRT dilemma. Kidney International 66, pages S41-S49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.